125 related articles for article (PubMed ID: 11164892)
1. IL-4 induces serine phosphorylation of the STAT6 transactivation domain in B lymphocytes.
Wick KR; Berton MT
Mol Immunol; 2000 Aug; 37(11):641-52. PubMed ID: 11164892
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-4-induced transcriptional activation by stat6 involves multiple serine/threonine kinase pathways and serine phosphorylation of stat6.
Pesu M; Takaluoma K; Aittomäki S; Lagerstedt A; Saksela K; Kovanen PE; Silvennoinen O
Blood; 2000 Jan; 95(2):494-502. PubMed ID: 10627454
[TBL] [Abstract][Full Text] [Related]
3. p38 Mitogen-activated protein kinase regulates interleukin-4-induced gene expression by stimulating STAT6-mediated transcription.
Pesu M; Aittomäki S; Takaluoma K; Lagerstedt A; Silvennoinen O
J Biol Chem; 2002 Oct; 277(41):38254-61. PubMed ID: 12161424
[TBL] [Abstract][Full Text] [Related]
4. Multiple signaling pathways mediate interleukin-4-induced 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene expression in human breast cancer cells.
Gingras S; Côté S; Simard J
Mol Endocrinol; 2000 Feb; 14(2):229-40. PubMed ID: 10674396
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 4 regulates phosphorylation of serine 756 in the transactivation domain of Stat6. Roles for multiple phosphorylation sites and Stat6 function.
Wang Y; Malabarba MG; Nagy ZS; Kirken RA
J Biol Chem; 2004 Jun; 279(24):25196-203. PubMed ID: 15069079
[TBL] [Abstract][Full Text] [Related]
6. IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells.
Ahmad F; Gao G; Wang LM; Landstrom TR; Degerman E; Pierce JH; Manganiello VC
J Immunol; 1999 Apr; 162(8):4864-75. PubMed ID: 10202031
[TBL] [Abstract][Full Text] [Related]
7. IL-6 mediated activation of STAT3 bypasses Janus kinases in terminally differentiated B lineage cells.
Kopantzev Y; Heller M; Swaminathan N; Rudikoff S
Oncogene; 2002 Oct; 21(44):6791-800. PubMed ID: 12360405
[TBL] [Abstract][Full Text] [Related]
8. Costimulation of resting B lymphocytes alters the IL-4-activated IRS2 signaling pathway in a STAT6 independent manner: implications for cell survival and proliferation.
Zamorano J; Kelly AE; Austrian J; Wang HY; Keegan AD
Cell Res; 2001 Mar; 11(1):44-54. PubMed ID: 11305324
[TBL] [Abstract][Full Text] [Related]
9. IL-13 induces phosphorylation and activation of JAK2 Janus kinase in human colon carcinoma cell lines: similarities between IL-4 and IL-13 signaling.
Murata T; Noguchi PD; Puri RK
J Immunol; 1996 Apr; 156(8):2972-8. PubMed ID: 8609418
[TBL] [Abstract][Full Text] [Related]
10. The IL-4 receptor alpha-chain cytoplasmic domain is sufficient for activation of JAK-1 and STAT6 and the induction of IL-4-specific gene expression.
Reichel M; Nelson BH; Greenberg PD; Rothman PB
J Immunol; 1997 Jun; 158(12):5860-7. PubMed ID: 9190938
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of JAK3 and STAT6 tyrosine phosphorylation by the immunosuppressive drug leflunomide leads to a block in IgG1 production.
Siemasko K; Chong AS; Jäck HM; Gong H; Williams JW; Finnegan A
J Immunol; 1998 Feb; 160(4):1581-8. PubMed ID: 9469413
[TBL] [Abstract][Full Text] [Related]
12. Comparison of IL-13- and IL-4-induced signaling in EBV-immortalized human B cells.
Murata T; Puri RK
Cell Immunol; 1997 Jan; 175(1):33-40. PubMed ID: 9015186
[TBL] [Abstract][Full Text] [Related]
13. Identification of the critical portions of the human IL-4 receptor alpha chain for activation of STAT6.
Harada N; Higuchi K; Wakao H; Hamasaki N; Izuhara K
Biochem Biophys Res Commun; 1998 May; 246(3):675-80. PubMed ID: 9618271
[TBL] [Abstract][Full Text] [Related]
14. Serine phosphorylation of Stat6 negatively controls its DNA-binding function.
Maiti NR; Sharma P; Harbor PC; Haque SJ
J Interferon Cytokine Res; 2005 Sep; 25(9):553-63. PubMed ID: 16181056
[TBL] [Abstract][Full Text] [Related]
15. Mitogenic synergy through multilevel convergence of hepatocyte growth factor and interleukin-4 signaling pathways.
Day RM; Soon L; Breckenridge D; Bridges B; Patel BK; Wang LM; Corey SJ; Bottaro DP
Oncogene; 2002 Mar; 21(14):2201-11. PubMed ID: 11948403
[TBL] [Abstract][Full Text] [Related]
16. Cutting edge: IL-4 induces suppressor of cytokine signaling-3 expression in B cells by a mechanism dependent on activation of p38 MAPK.
Canfield S; Lee Y; Schröder A; Rothman P
J Immunol; 2005 Mar; 174(5):2494-8. PubMed ID: 15728454
[TBL] [Abstract][Full Text] [Related]
17. Phytochemical inhibition of interleukin-4-activated Stat6 and expression of VCAM-1.
Schnyder B; Schnyder-Candrian S; Panski A; Bömmel H; Heim M; Duschl A; Moser R
Biochem Biophys Res Commun; 2002 Apr; 292(4):841-7. PubMed ID: 11944890
[TBL] [Abstract][Full Text] [Related]
18. Antigen receptor signal transduction: activating and inhibitory antigen receptors regulate STAT1 serine phosphorylation.
Lafont V; Decker T; Cantrell D
Eur J Immunol; 2000 Jul; 30(7):1851-60. PubMed ID: 10940874
[TBL] [Abstract][Full Text] [Related]
19. The YXXQ motif in gp 130 is crucial for STAT3 phosphorylation at Ser727 through an H7-sensitive kinase pathway.
Abe K; Hirai M; Mizuno K; Higashi N; Sekimoto T; Miki T; Hirano T; Nakajima K
Oncogene; 2001 Jun; 20(27):3464-74. PubMed ID: 11429693
[TBL] [Abstract][Full Text] [Related]
20. The SH3-SAM adaptor HACS1 is up-regulated in B cell activation signaling cascades.
Zhu YX; Benn S; Li ZH; Wei E; Masih-Khan E; Trieu Y; Bali M; McGlade CJ; Claudio JO; Stewart AK
J Exp Med; 2004 Sep; 200(6):737-47. PubMed ID: 15381729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
